Strain-dependent structural variants of herpes simplex virus type 1 ICP34.5 Determine viral plaque size, efficiency of glycoprotein processing, and viral release and neuroinvasive disease potential

Journal of Virology

Volumn 77, Issue 6, 2003, Pages 3409-3417

  Mao, Hanwen ^a,b   Rosenthal, Ken S ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GENE PRODUCT; GLYCOPROTEIN; PROLINE; THREONINE; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; INFECTION; NONHUMAN; PHENOTYPE; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENE; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CERCOPITHECUS AETHIOPS; ENCEPHALITIS, HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; MALE; MICE; MICE, INBRED BALB C; PLAQUE ASSAY; RECOMBINATION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; VARIATION (GENETICS); VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 0037334083     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.6.3409-3417.2003     Document Type: Article

References (47)

1. Ackermann, M., J. Chou, M. Sarmiento, R. A. Lerner, and B. Roizman. 1986. Identification by antibody to a synthetic peptide of a protein specified by a diploid gene located in the terminal repeats of the L component of herpes simplex virus genome. J. Virol. 58:843-850.
2. Allan, V. 1995. Protein phosphatase 1 regulates the cytoplasmic dynein-driven formation of endoplasmic reticulum networks in vitro. J. Cell Biol. 128:879-891.
3. Allen, P. B., Y. G. Kwon, A. C. Nairn, and P. Greengard. 1998. Isolation and characterization of PNUTS, a putative protein phosphatase 1 nuclear targeting subunit. J. Biol. Chem. 273:4089-4095.
4. Allen, P. B., C. C. Ouimet, and P. Greengard. 1997. Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc. Natl. Acad. Sci. USA 94:9956-9961.
5. Bergstrom, T., A. Vahlne, K. Alestig, S. Jeansson, M. Forsgren, and E. Lycke. 1990. Primary and recurrent herpes simplex virus type 2-induced meningitis. J. Infect. Dis. 162:322-330.
6. Bolovan, C. A., N. M. Sawtell, and R. L. Thompson. 1994. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J. Virol. 68:48-55.
7. Bower, J. R., H. Mao, C. Durishin, E. Rozenbom, M. Detwiler, D. Rempinski, T. L. Karban, and K. S. Rosenthal. 1999. Intrastrain variants of HSV-1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasive disease. J. Virol. 73:3843-3853.
8. Brown, S. M., A. R. MacLean, J. D. Aitken, and J. Harland. 1994. ICP 34.5 influences herpes simplex virus type 1 maturation and egress from infected cells in vitro. J. Gen. Virol. 75:3679-3686.
9. Brown, S. M., A. R. MacLean, E. A. McKie, and J. Harland. 1997. The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34. J. Virol. 71:9442-9449.
10. 134.5 protein of herpes simplex virus type 1. J. Virol. 76:9434-9445.
11. - mutants of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 92:10516-10520.
12. 134.5, a gene nonessential for growth in cell culture. Science 252:1262-1266.
13. Chou, J., and B. Roizman. 1990. The herpes simplex virus 1 gene for ICP34.5, which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17syn+. J. Virol. 64:1014-1020.
14. 1 34.5 gene of herpes simplex virus precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA 9:3266-3270.
15. Chou, J., and B. Roizman. 1994. Herpes simplex virus gamma-1 34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proc. Natl. Acad. Sci. USA 91:5247-5251.
16. Craig, C. P., and A. J. Nahmias. 1973. Different patterns of neurologic involvement with herpes simplex virus types 1 and 2: isolation of herpes simplex virus type 2 from the buffy coat of two adults with meningitis. J. Infect. Dis. 127:365-372.
17. Davidson, H. W., C. H. McGowan, and W. E. Balch. 1992. Evidence for the regulation of exocytic transport by protein phosphorylation. J. Biol. Chem. 116:1343-1355.
18. Dick, J. W., and K. S. Rosenthal. 1995. A block in glycoprotein processing correlates with small plaque morphology and virion targeting to cell-cell junctions for an oral and an anal strain of herpes simplex virus type-1. Arch. Virol. 140:2163-2181.
19. Dix, R. D., R. R. McKendall, and J. R. Baringer. 1983. Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect. Immun. 40:103-112.
20. Enquist, L. W., P. J. Husak, B. W. Banfield, and G. A. Smith. 1999. Infection and spread of alphaherpesviruses in the nervous system. Adv. Virol. Res. 51:237-347.
21. Goel, N., H. Mao, Q. Rong, J. J. Docherty, D. Zimmerman, and K. S. Rosenthal. 2002. The ability of an HSV strain to initiate zosteriform spread correlates with its neuroinvasive disease potential. Arch. Virol. 147:763-773.
22. He, B., J. Chou, D. A. Liebermann, B. Hoffman, and B. Roizman. 1996. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma-1 ICP34.5 of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J. Virol. 70:84-90.
23. He, B., M. Gross, and B. Roizman. 1997. The γ-1 34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94:843-848.
24. He, B., M. Gross, and B. Roizman. 1998. The γ-1 34.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells. J. Biol. Chem. 273:20737-20743.
25. Holland, T. C., S. D. Marlin, M. Levine, and J. Glorioso. 1983. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies. J. Virol. 45:672-682.
26. Izumi, K. M., and J. G. Stevens. 1990. Molecular and biological characterization of an HSV-1 neuroinvasion gene. J. Exp. Med. 172:487-496.
27. Leib, D. A., T. E. Harrison, K. M. Laslo, M. A. Machalek, N. J. Moorman, and H. W. Virgin. 1999. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189:663-672.
28. Leib, D. A., M. A. Machalek, B. R. G. Williams, R. H. Silverman, and W. V. Herbert. 2000. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl. Acad. Sci. USA 97:6097-6101.
29. Lerner, A. M., and E. J. Bailey. 1976. Differential sensitivity of SHV types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine. J. Infect. Dis. 134:400-404.
30. Leventon-Kriss, S., M. Movshovitz, Z. Smetana, M. Shewach-Millet, T. Doerner, and T. Gotlieb-Stematsky. 1987. Sensitivity in vitro of herpes simplex virus isolates to human fibroblast interferon. Med. Microbiol. Immunol. 176:151-159.
31. MacLean, A., L. Robertson, E. McKay, and S. M. Brown. 1991. The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency. J. Gen. Virol. 72:2305-2310.
32. Mao, H., and K. S. Rosenthal. 2002. An N-terminal arginine-rich cluster and a proline-alanine-threonine repeat region determine the cellular localization of the herpes simplex virus type 1 ICP34.5 protein and its ligand protein phosphatase 1. J. Biol. Chem. 277:11423-11431.
33. McGeoch, D. J., C. Cunningham, G. McIntyre, and A. Dolan. 1991. Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. J. Gen. Virol. 72:3057-3075.
34. Mitchell, B. M., and J. G. Stevens. 1996. Neuroinvasive properties of herpes simplex virus type I glycoprotein variants are controlled by the immune response. J. Immunol. 156:246-255.
35. Mossman, K. L., and J. R. Smiley. 2002. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J. Virol. 76:1995-1998.
36. Perng, G. C., R. L. Thompson, N. M. Sawtell, W. E. Taylor, S. M. Slanina, H. Ghiasl, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1995. An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J. Virol. 69:3033-3041.
37. Peters, C., P. D. Andrews, M. J. Stark, S. Cesaro-Tadic, A. Glatz, A. Podtelejnikov, M. Mann, and A. Mayer. 1999. Control of the terminal step of intracellular membrane fusion by protein phosphatase 1. Science 285:1084-1087.
38. Ravi, V., P. G. Kennedy, and A. R. MacLean. 1998. Functional analysis of the herpes simplex virus type 2 strain HG52 RL1 gene: the intron plays no role in virulence. J. Gen. Virol. 79:1613-1617.
39. Robbins, A. K., M. E. Whealy, and L. W. Enquist. 1988. Centrifugation procedures for studying herpes viruses using the Sorvall RC-28 SUPRAspeed centrifuge. Dupont Biotech. Update 3:1-3.
40. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
41. Terry-Lorenzo, R. T., M. Inoue, J. H. Connor, T. A. J. Haystead, B. N. Armbruster, R. P. Gupta, C. J. Oliver, and S. Shenolikar. 2000. Neurofilament-L is a protein phosphatase-1-binding protein associated with neuronal plasma membrane and post-synaptic density. J. Biol. Chem. 275:2439-2446.
42. Thomas, H. C., R. D. Kapadia, G. I. Wells, A. M. Gresham, D. Sutton, H. A. Solleveld, S. K. Sarkar, S. B. Dillon, and R. Tal-Singer. 2001. Differences in pathogenicity of herpes simplex virus serotypes 1 and 2 may be observed by histopathology and high-resolution magnetic resonance imaging in a murine encephalitis model. J. Neurovirol. 7:105-116.
43. Thompson, R. L., M. L. Cook, G. B. Devi-Rao, E. K. Wagner, and J. G. Stevens. 1986. Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS. J. Virol. 58:203-211.
44. Trgovcich, J., D. Johnson, and B. Roizman. 2002. Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma-1 34.5 and Ul41 genes of herpes simplex virus 1. J. Virol. 76:6974-6986.
45. Yuhasz, S. A., and J. G. Stevens. 1993. Glycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasiveness. J. Virol. 67:5948-5954.
46. Zon, L. I., D. M. Dorfman, and S. H. Orkin. 1989. The polymerase chain reaction colony minipre. Biotechniques 7:696-698.
47. Zon, L. I., D. M. Dorfman, and S. H. Orkin. 1989. The polymerase chain reaction colony miniprep. Biotechniques 7:696-698.